Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022

SELL
$11.96 - $19.35 $502 - $812
-42 Closed
0 $0
Q3 2021

Nov 10, 2021

SELL
$17.35 - $24.87 $294 - $422
-17 Reduced 28.81%
42 $1,000
Q2 2021

Aug 09, 2021

SELL
$14.25 - $30.93 $213 - $463
-15 Reduced 20.27%
59 $1,000
Q1 2021

May 14, 2021

BUY
$10.43 - $17.8 $771 - $1,317
74 New
74 $1,000

Others Institutions Holding CELC

About Celcuity Inc.


  • Ticker CELC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,941,300
  • Market Cap $190M
  • Description
  • Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...
More about CELC
Track This Portfolio

Track O'Shaughnessy Asset Management, LLC Portfolio

Follow O'Shaughnessy Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of O'Shaughnessy Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on O'Shaughnessy Asset Management, LLC with notifications on news.